Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

[Autosomal dominant polycystic kidney disease in hemodialysis patients in Southern Brazil].

Alves EF, Tsuneto LT, Pelloso SM, Torres PR, Otto GL, Silva AA, Obregon JM, Silva LN, Carvalho MD.

J Bras Nefrol. 2014 Jan-Mar;36(1):18-25. Portuguese.

2.

Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.

Nunes AC, Milani V, Porsch DB, Rossato LB, Mattos CB, Roisenberg I, Barros EJ.

Ren Fail. 2008;30(2):169-73. doi: 10.1080/08860220701810265.

PMID:
18300116
3.

[Active uremia therapy in autosomal dominant polycystic kidney disease].

Katre S, Leivestad T, Fauchald P.

Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1015-9. Norwegian.

4.

Changing referral characteristics of patients with autosomal dominant polycystic kidney disease.

Helal I, McFann K, Reed B, Yan XD, Schrier RW.

Am J Med. 2013 Sep;126(9):832.e7-832.e11. doi: 10.1016/j.amjmed.2012.12.018. Epub 2013 Jul 3.

PMID:
23830538
5.

Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.

Christophe JL, van Ypersele de Strihou C, Pirson Y.

Nephrol Dial Transplant. 1996 Jul;11(7):1271-6.

PMID:
8672022
6.

Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.

Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, Kurokawa K.

Nephron. 1998 Dec;80(4):421-7.

PMID:
9832641
7.

Demographic and clinical characteristics of patients with autosomal dominant polycystic kidney disease: a multicenter experience.

Kazancioglu R, Ecder T, Altintepe L, Altiparmak MR, Tuglular S, Uyanik A, Cavdar C, Ecder SA, Tokgoz B, Duman N, Duzova A, Cetinkaya R; Turkish Society of Nephrology Polycystic Kidney Disease Working Group..

Nephron Clin Pract. 2011;117(3):c270-5. doi: 10.1159/000320745. Epub 2010 Sep 17.

PMID:
20847569
8.

Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease.

Haseebuddin M, Tanagho YS, Millar M, Roytman T, Chen C, Clayman RV, Miller B, Desai A, Benway B, Bhayani S, Figenshau RS.

J Urol. 2012 Oct;188(4):1239-44. doi: 10.1016/j.juro.2012.06.026. Epub 2012 Aug 16.

PMID:
22902029
9.

[Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].

Saima S, Suzuki Y, Yoshimoto K, Nakamura Y, Munakata A.

Nihon Jinzo Gakkai Shi. 1996 Jun;38(6):278-84. Japanese.

PMID:
8752971
10.

[Autosomal dominant polycystic kidney disease: light at the end of the tunnel?].

Melander C, Joly D, Knebelmann B.

Nephrol Ther. 2010 Jul;6(4):226-31. doi: 10.1016/j.nephro.2010.02.004. Epub 2010 Apr 28. Review. French.

PMID:
20430712
11.

Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease.

Ishikawa I, Maeda K, Nakai S, Kawaguchi Y.

Am J Kidney Dis. 2000 Jun;35(6):1072-5.

PMID:
10845819
12.

Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens.

Jilg CA, Drendel V, Bacher J, Pisarski P, Neeff H, Drognitz O, Schwardt M, Gläsker S, Malinoc A, Erlic Z, Nunez M, Weber A, Azurmendi P, Schultze-Seemann W, Werner M, Neumann HP.

Nephron Clin Pract. 2013;123(1-2):13-21. doi: 10.1159/000351049. Epub 2013 Jun 4.

PMID:
23752029
13.
14.
15.

[Renal replacement therapy in adult dominant polycystic kidney disease--multicentre study].

Lezaić V, Ostrić V, Popović G, Vukoje M, Dragolić B, Kostić N, Stojanović M, Labudović M, Mandić M, Djordjević V, Baković J.

Srp Arh Celok Lek. 2008 Dec;136 Suppl 4:287-93. Serbian.

16.

[Clinical analysis of a population with autosomal dominant polycystic kidney disease].

Gómez PF, García-Cosmes P, Becerra LG, Romo JM.

Nefrologia. 2010;30(1):87-94. doi: 10.3265/Nefrologia.pre2010.Jan.10211. Spanish.

17.

Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-related malignancies and cardiovascular risk factors.

Errasti P, Manrique J, Lavilla J, Rossich E, Hernandez A, Pujante D, Ndarabu A, García N, Purroy A.

Transplant Proc. 2003 Aug;35(5):1717-9.

PMID:
12962769
18.

Spanish guidelines for the management of autosomal dominant polycystic kidney disease.

Ars E, Bernis C, Fraga G, Martínez V, Martins J, Ortiz A, Rodríguez-Pérez JC, Sans L, Torra R; Spanish Working Group on Inherited Kidney Disease..

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv95-105. doi: 10.1093/ndt/gfu186.

PMID:
25165191
19.

CAPD in patients with autosomal dominant polycystic kidney disease.

Hadimeri H, Johansson AC, Haraldsson B, Nyberg G.

Perit Dial Int. 1998 Jul-Aug;18(4):429-32.

PMID:
10505567
20.

Intravascular embolization therapy in patients with enlarged polycystic liver.

Hoshino J, Ubara Y, Suwabe T, Sumida K, Hayami N, Mise K, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Takei R, Takaichi K.

Am J Kidney Dis. 2014 Jun;63(6):937-44. doi: 10.1053/j.ajkd.2014.01.422. Epub 2014 Mar 4.

PMID:
24602778

Supplemental Content

Support Center